Nestec S.a.

Societe Des Produits Nestle S.a.

Bertrand Bourqui

Serge Andre Dominique Rezzi

Stephane Duboux

Philippe Alexandre Guy

Nicolas Page

Francis Foata

Francia Jacqueline Arce Vera

Timo Buetler

Nicola Galaffu

Edwin Alberto Habeych Narvaez

Irma Silva Zolezzi

Joeska Husny

Sara Colombo Mottaz

Sophie Moille

Marjorie Guitard

Sylvain Lengacher

Pierre Julius Magistretti

Jane Durga

Evelyne Ruchti

Igor Allaman

Rafael Berrocal Flores

Antoine Jean-Pierre Roux

Stéphane Duboux

Serge André Dominique Rezzi

An oral composition comprising at least one probiotic bacteria selected from the genera:, and, and ferric pyrophosphate.

Dietary supplement

The present invention relates to a composition in powder form comprising probiotic bacteria and at least one iron source selected from ferrous citrate, ferric citrate, ferrous sulphate monohydrate and mixtures thereof. Ferrous citrate, ferric citrate, ferrous sulphate monohydrate and mixtures thereof advantageously do not cause significant inhibition or reduction in the viability of the bacteria and thus these iron sources are advantageously used to fortify a composition in powder form comprising probiotic bacteria.

Composition in powder form comprising iron and probiotic bacteria

The present invention relates to a composition in powder form comprising probiotic bacteria and at least one iron-milk protein complex. Such iron-milk protein complex advantageously does not cause significant reduction in the viability of the bacteria and thus such iron source is advantageously used to fortify a composition in powder form comprising probiotic bacteria.

Composition in powder form comprising iron-milk protein complexes and probiotic bacteria

The present invention relates generally to the field of enhancing skin appearance. One aspect of the invention aims to provide a composition comprising 4-oxo-2-pentenoic acid for use in the reduction or prevention of regions of the skin with darker pigmentation. The present invention also relates to cosmetic use of a composition comprising 4-oxo-2-pentenoic acid for the reduction or prevention of regions of the skin with darker pigmentation.

4-oxo-2-pentenoic acid and skin pigmentation

The present invention relates generally to compositions with a health benefit. In particular, the invention relates to treatment or prevention of liver disorders. A subject matter of the invention is a composition comprising 4-oxo-2-pentenoic acid for use in the treatment or prevention of liver disorders. A further subject matter of the invention is a composition comprising 4-oxo-2-pentenoic acid for use in the treatment or prevention of liver disorders linked to an insufficient activity of phase II enzymes in the liver.

4-oxo-2-pentenoic acid and liver disorders

The present invention relates generally to compositions with a health benefit. In particular, the invention relates to the field of brain health, for example brain protection, maintenance of cognitive function, prevention of cognitive decline and prevention of cognitive disorders. A subject matter of the invention is a composition comprising 4-oxo-2-pentenoic acid for use in the treatment or prevention of cognitive decline.

4-oxo-2-pentenoic acid and brain health

The present invention relates generally to compositions with a health benefit. In particular, the invention relates to the field of cardiovascular disorders, for example, atherosclerosis, high blood pressure, coronary heart disease, myocardial infarction, angina pectoris, stroke, and heart failure. A subject matter of the invention is a composition comprising 4-oxo-2-pentenoic acid for use in the treatment or prevention of cardiovascular disorders.

4-oxo-2-pentenoic acid and cardiovascular health

Growing community of inventors

Murist, Switzerland

Bertrand Bourqui